Technical Analysis for QURE - uniQure N.V.

Grade Last Price % Change Price Change
grade B 38.46 -6.51% -2.68
QURE closed down 6.51 percent on Friday, September 21, 2018, on approximately normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Down
See historical QURE trend table...

Date Alert Name Type % Chg
Sep 21 Fell Below 20 DMA Bearish 0.00%
Sep 21 Bollinger Band Squeeze Range Contraction 0.00%
Sep 21 Multiple of Ten Bearish Other 0.00%
Sep 21 Outside Day Range Expansion 0.00%
Sep 20 Crossed Above 20 DMA Bullish -6.51%
Sep 20 180 Bullish Setup Bullish Swing Setup -6.51%
Sep 20 Bollinger Band Squeeze Range Contraction -6.51%
Sep 20 Multiple of Ten Bullish Other -6.51%
Sep 19 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -0.26%
Sep 19 Bollinger Band Squeeze Range Contraction -0.26%

Older signals for QURE ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
uniQure BV, a biopharmaceutical company, develops gene therapies through its modular technology platform for the treatment of genetic or acquired diseases. The company offers Glybera for the treatment of patients with lipoprotein lipase deficiency, an orphan metabolic disease. It also develops a pipeline of additional adeno-associated virus (AAV) based gene therapies, including AMT-060, a gene therapy for the treatment of hemophilia B; AMT-021 for acute intermittent porphyria; AMT-110 for Sanfilippo B syndrome; and AAV2/glial cell line-derived neurotrophic factor for Parkinson's disease, as well as various programs that are in early preclinical development stage. The company has collaborations with Chiesi Farmaceutici S.p.A., Digna Biotech, Institut Pasteur, and University of California San Francisco. uniQure BV was founded in 1998 and is headquartered in Amsterdam, the Netherlands.
Is QURE a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 43.23
52 Week Low 8.66
Average Volume 269,354
200-Day Moving Average 29.1804
50-Day Moving Average 36.9086
20-Day Moving Average 40.673
10-Day Moving Average 40.122
Average True Range 2.0489
ADX 16.34
+DI 18.2023
-DI 18.4446
Chandelier Exit (Long, 3 ATRs ) 37.0833
Chandelier Exit (Short, 3 ATRs ) 44.1567
Upper Bollinger Band 43.5451
Lower Bollinger Band 37.8009
Percent B (%b) 0.11
BandWidth 14.122883
MACD Line 0.5949
MACD Signal Line 1.0373
MACD Histogram -0.4424
Fundamentals Value
Market Cap 983.03 Million
Num Shares 25.6 Million
EPS -2.82
Price-to-Earnings (P/E) Ratio -13.64
Price-to-Sales 16.30
Price-to-Book 14.70
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 44.21
Resistance 3 (R3) 44.69 43.27 43.25
Resistance 2 (R2) 43.27 41.80 43.02 42.93
Resistance 1 (R1) 40.86 40.90 40.15 40.38 42.61
Pivot Point 39.44 39.44 39.08 39.19 39.44
Support 1 (S1) 37.03 37.97 36.32 36.55 34.31
Support 2 (S2) 35.61 37.07 35.36 33.99
Support 3 (S3) 33.20 35.61 33.67
Support 4 (S4) 32.72